• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES, PR FOGARTY THRU-LUMEN EMBOLECTOMY CATHETER; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES, PR FOGARTY THRU-LUMEN EMBOLECTOMY CATHETER; CATHETER, EMBOLECTOMY Back to Search Results
Model Number 12TLW803F
Medical Device Problem Code Burst Container or Vessel (1074)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/09/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
One fogarty embolectomy catheter was received by our product evaluation laboratory for a full examination.The report of "leakage" was confirmed.As received, balloon was found to be ruptured at the central area.The edges of latex did not appear to match up.Both balloon windings were intact.Through lumen was patent without any leakage or occlusion.No visible damage was observed from catheter body.The manufacturing records were reviewed for the lot involved and there is no indication of a related nonconformance.All process parameters were met and inspections passed successfully.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Event or Problem Description
As reported, during use of this fogarty embolectomy catheter, a saline leakage was found.There was no allegation of patient injury.The device was received for evaluation.As per evaluation results, balloon was found to be ruptured at the central area.The edges of latex did not appear to match up.
 
Additional Manufacturer Narrative
Added information to section h6 (type of investigation) updated section h6 (component code), h6 (investigation findings) and h6 (investigations conclusions).Based on the available information there is no evidence that supports or confirms the failure mode is associated to a manufacturing or design defect.The controls to defect the failure mode being evaluated are established in the manufacturing process.As part of the manufacturing process the units go through balloon and winding inspection.Patient demographics unable to be obtained.Corrected data: corrected section g2 (other, specify) to china.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FOGARTY THRU-LUMEN EMBOLECTOMY CATHETER
Common Device Name
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco
Manufacturer (Section G)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco
Manufacturer Contact
samantha eveleigh
1 edwards way
irvine, CA 92614
9492503939
MDR Report Key22518955
Report Number2015691-2025-05777
Device Sequence Number20852843
Product Code DXE
UDI-Device Identifier00690103043501
UDI-Public(01)00690103043501(17)260903(11)240604(10)65443895
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K240078
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 08/01/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/03/2026
Device Model Number12TLW803F
Device Lot Number65443895
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/05/2025
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/27/2025
Supplement Date Received by Manufacturer07/24/2025
Initial Report FDA Received Date07/16/2025
Supplement Report FDA Received Date08/01/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/04/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-